1. Home
  2. ACXP vs SLNH Comparison

ACXP vs SLNH Comparison

Compare ACXP & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

SELL

Current Price

$1.00

Market Cap

5.8M

Sector

Health Care

ML Signal

SELL

Logo Soluna Holdings Inc.

SLNH

Soluna Holdings Inc.

SELL

Current Price

$0.41

Market Cap

126.7M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
ACXP
SLNH
Founded
2017
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
126.7M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
ACXP
SLNH
Price
$1.00
$0.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
★ $10.33
$2.75
AVG Volume (30 Days)
88.6K
★ 10.4M
Earning Date
11-12-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $38,021,000.00
Revenue This Year
N/A
$106.45
Revenue Next Year
N/A
$6.11
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 80.49
52 Week Low
$0.90
$0.40
52 Week High
$7.54
$2.36

Technical Indicators

Market Signals
Indicator
ACXP
SLNH
Relative Strength Index (RSI) 39.13 30.46
Support Level $0.95 N/A
Resistance Level $1.12 $1.34
Average True Range (ATR) 0.08 0.07
MACD 0.00 0.00
Stochastic Oscillator 38.63 4.85

Price Performance

Historical Comparison
ACXP
SLNH

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.

Share on Social Networks: